5-BPDI
Discover related
2 sources
Collated from TripSit, Pharmacology. Where sources differ (e.g. dosing), Compare shows them side by side.
An analogue of a-PHP, which has been described as having an extremely similar effect profile, with some users noting that it may be slightly lighter and with less of an urge to redose. However, little record of the safety of human use exists.TS
Oral
Route dataTripSit
| Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| — | 7.5–10 mg | 10–25 mg | 25–45 mg | —+ |
045 mg
LightCommonStrongHeavy
| After-effects | 3–8 hours |
|---|
🧬 Receptor activityPH
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Neuronal acetylcholine receptor; alpha4/beta2 | — | Ki 18700 nM | CHEMBL | TargetNeuronal acetylcholine receptor; alpha4/beta2 Action— AffinityKi 18700 nM SourceCHEMBL |
| Neuronal acetylcholine receptor subunit alpha-7 | — | Ki 100000 nM | CHEMBL | TargetNeuronal acetylcholine receptor subunit alpha-7 Action— AffinityKi 100000 nM SourceCHEMBL |
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.